![Sophia Park](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Sophia Park currently works at MyoKardia, Inc., as Vice President from 2020, Mirati Therapeutics, Inc., as Vice President from 2024, Rayzebio, Inc., as Vice President from 2024, and Karuna Therapeutics, Inc., as Vice President from 2024.
Cargos activos de Sophia Park
| Empresas | Cargo | Inicio |
|---|---|---|
| MYOKARDIA, INC. | Corporate Officer/Principal | 17/11/2020 |
| MIRATI THERAPEUTICS | Corporate Officer/Principal | 23/01/2024 |
| RAYZEBIO, INC. | Corporate Officer/Principal | 26/02/2024 |
| KARA THER | Corporate Officer/Principal | 18/03/2024 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
15
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease | Health Technology |
Rayzebio, Inc.
 Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
- Bolsa de valores
- Insiders
- Sophia Park
